Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men

Johannes D Veldhuis, Dana Erickson, Jean Wigham, Sue Weist, John M. Miles, Cyril Y. Bowers

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Context: GH negatively regulates its own secretion. How gender, sex steroids, and secretagogues modulate GH autofeedback is not known. Hypothesis/Objective: Supplementation with sex steroids and/or a peptidyl secretagogue will enhance the escape of GH from autoinhibition, thus framing a mechanism for amplifying pulsatile GH secretion. Subjects and Setting: Ten healthy postmenopausal women and 10 comparably aged men participated at the Clinical-Translational Science Unit. Design/Interventions: Randomly ordered, double-blind, prospective crossover treatment with placebo vs. testosterone (men) or placebo vs. estradiol (women). Autofeedback was imposed by an iv pulse of GH. Recovery of feedback inhibition was quantified during constant infusion of saline, GHRH, or GH-releasing peptide-2 (three peptide categories). Outcomes/Results: During negative feedback, total (integrated) GH recovery depended upon gender (P = 0.017), sex hormone (P < 0.001), and peptide category (P < 0.001). Mechanistic analysis revealed that feedback-suppressed nadir GH concentrations were determined by sex-steroid treatment (P = 0.018) but not by gender (P = 0.444). Peak GH escape was controlled by both treatment (P = 0.004) and gender (P = 0.003). Nadir GH and peak GH during feedback were enhanced by GHRH or GHRP-2 (P < 0.001 for both). Gender x peptide (P = 0.012 for nadir GH), treatment x peptide (P < 0.001 total and peak GH), and gender x treatment (P = 0.017 nadir GH) regulated GH recovery interactively. Conclusion: Gender, sex-steroid supplementation, and secretagogue type confer distinct feedback-rescuing effects, introducing a new level of complexity in the control of pulsatile GH regulation.

Original languageEnglish (US)
Pages (from-to)2540-2547
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume96
Issue number8
DOIs
StatePublished - Aug 2011

Fingerprint

Growth Hormone
Steroids
Feedback
Recovery
Placebos
Therapeutics
Peptides
Gonadal Steroid Hormones
Testosterone
Estradiol
peptide P

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men. / Veldhuis, Johannes D; Erickson, Dana; Wigham, Jean; Weist, Sue; Miles, John M.; Bowers, Cyril Y.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 96, No. 8, 08.2011, p. 2540-2547.

Research output: Contribution to journalArticle

Veldhuis, Johannes D ; Erickson, Dana ; Wigham, Jean ; Weist, Sue ; Miles, John M. ; Bowers, Cyril Y. / Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men. In: Journal of Clinical Endocrinology and Metabolism. 2011 ; Vol. 96, No. 8. pp. 2540-2547.
@article{f2e3b3413d194fe889b459e734d30e2d,
title = "Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men",
abstract = "Context: GH negatively regulates its own secretion. How gender, sex steroids, and secretagogues modulate GH autofeedback is not known. Hypothesis/Objective: Supplementation with sex steroids and/or a peptidyl secretagogue will enhance the escape of GH from autoinhibition, thus framing a mechanism for amplifying pulsatile GH secretion. Subjects and Setting: Ten healthy postmenopausal women and 10 comparably aged men participated at the Clinical-Translational Science Unit. Design/Interventions: Randomly ordered, double-blind, prospective crossover treatment with placebo vs. testosterone (men) or placebo vs. estradiol (women). Autofeedback was imposed by an iv pulse of GH. Recovery of feedback inhibition was quantified during constant infusion of saline, GHRH, or GH-releasing peptide-2 (three peptide categories). Outcomes/Results: During negative feedback, total (integrated) GH recovery depended upon gender (P = 0.017), sex hormone (P < 0.001), and peptide category (P < 0.001). Mechanistic analysis revealed that feedback-suppressed nadir GH concentrations were determined by sex-steroid treatment (P = 0.018) but not by gender (P = 0.444). Peak GH escape was controlled by both treatment (P = 0.004) and gender (P = 0.003). Nadir GH and peak GH during feedback were enhanced by GHRH or GHRP-2 (P < 0.001 for both). Gender x peptide (P = 0.012 for nadir GH), treatment x peptide (P < 0.001 total and peak GH), and gender x treatment (P = 0.017 nadir GH) regulated GH recovery interactively. Conclusion: Gender, sex-steroid supplementation, and secretagogue type confer distinct feedback-rescuing effects, introducing a new level of complexity in the control of pulsatile GH regulation.",
author = "Veldhuis, {Johannes D} and Dana Erickson and Jean Wigham and Sue Weist and Miles, {John M.} and Bowers, {Cyril Y.}",
year = "2011",
month = "8",
doi = "10.1210/jc.2011-0298",
language = "English (US)",
volume = "96",
pages = "2540--2547",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men

AU - Veldhuis, Johannes D

AU - Erickson, Dana

AU - Wigham, Jean

AU - Weist, Sue

AU - Miles, John M.

AU - Bowers, Cyril Y.

PY - 2011/8

Y1 - 2011/8

N2 - Context: GH negatively regulates its own secretion. How gender, sex steroids, and secretagogues modulate GH autofeedback is not known. Hypothesis/Objective: Supplementation with sex steroids and/or a peptidyl secretagogue will enhance the escape of GH from autoinhibition, thus framing a mechanism for amplifying pulsatile GH secretion. Subjects and Setting: Ten healthy postmenopausal women and 10 comparably aged men participated at the Clinical-Translational Science Unit. Design/Interventions: Randomly ordered, double-blind, prospective crossover treatment with placebo vs. testosterone (men) or placebo vs. estradiol (women). Autofeedback was imposed by an iv pulse of GH. Recovery of feedback inhibition was quantified during constant infusion of saline, GHRH, or GH-releasing peptide-2 (three peptide categories). Outcomes/Results: During negative feedback, total (integrated) GH recovery depended upon gender (P = 0.017), sex hormone (P < 0.001), and peptide category (P < 0.001). Mechanistic analysis revealed that feedback-suppressed nadir GH concentrations were determined by sex-steroid treatment (P = 0.018) but not by gender (P = 0.444). Peak GH escape was controlled by both treatment (P = 0.004) and gender (P = 0.003). Nadir GH and peak GH during feedback were enhanced by GHRH or GHRP-2 (P < 0.001 for both). Gender x peptide (P = 0.012 for nadir GH), treatment x peptide (P < 0.001 total and peak GH), and gender x treatment (P = 0.017 nadir GH) regulated GH recovery interactively. Conclusion: Gender, sex-steroid supplementation, and secretagogue type confer distinct feedback-rescuing effects, introducing a new level of complexity in the control of pulsatile GH regulation.

AB - Context: GH negatively regulates its own secretion. How gender, sex steroids, and secretagogues modulate GH autofeedback is not known. Hypothesis/Objective: Supplementation with sex steroids and/or a peptidyl secretagogue will enhance the escape of GH from autoinhibition, thus framing a mechanism for amplifying pulsatile GH secretion. Subjects and Setting: Ten healthy postmenopausal women and 10 comparably aged men participated at the Clinical-Translational Science Unit. Design/Interventions: Randomly ordered, double-blind, prospective crossover treatment with placebo vs. testosterone (men) or placebo vs. estradiol (women). Autofeedback was imposed by an iv pulse of GH. Recovery of feedback inhibition was quantified during constant infusion of saline, GHRH, or GH-releasing peptide-2 (three peptide categories). Outcomes/Results: During negative feedback, total (integrated) GH recovery depended upon gender (P = 0.017), sex hormone (P < 0.001), and peptide category (P < 0.001). Mechanistic analysis revealed that feedback-suppressed nadir GH concentrations were determined by sex-steroid treatment (P = 0.018) but not by gender (P = 0.444). Peak GH escape was controlled by both treatment (P = 0.004) and gender (P = 0.003). Nadir GH and peak GH during feedback were enhanced by GHRH or GHRP-2 (P < 0.001 for both). Gender x peptide (P = 0.012 for nadir GH), treatment x peptide (P < 0.001 total and peak GH), and gender x treatment (P = 0.017 nadir GH) regulated GH recovery interactively. Conclusion: Gender, sex-steroid supplementation, and secretagogue type confer distinct feedback-rescuing effects, introducing a new level of complexity in the control of pulsatile GH regulation.

UR - http://www.scopus.com/inward/record.url?scp=79961229139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961229139&partnerID=8YFLogxK

U2 - 10.1210/jc.2011-0298

DO - 10.1210/jc.2011-0298

M3 - Article

VL - 96

SP - 2540

EP - 2547

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 8

ER -